Homepage
Catalog of Screening Compounds Screening Libraries Focused and Target Libraries Active Reference Sets Diversity Libraries
Screening Compounds Building blocks
Drug Discovery Services Custom Chemistry Medicinal chemistry In silico Drug Design (CADD) Discovery Biology Animal Models Toxicology and Safety ADME, DMPK Chemistry, Manufacturing and Controls
Company News & Media Contact us For suppliers Trends in discovery compounds
Homepage > Company > Media > Pharma News

Pharma News

Working out on a Friday means you can lounge around at the weekend without gaining weight because the effects of exercise last two days, study finds
Working out on a Friday means you can lounge around at the weekend without gaining weight because the effects of exercise last two days, study finds
If you've got plans to spend the entire weekend sat down scoffing food, there is no reason to feel guilty - as long as you exercise on the Friday.
Johnson & Johnson pays $300m to develop cusatuzumab
Johnson & Johnson pays $300m to develop cusatuzumab
Johnson & Johnson's Janssen has entered into an agreement potentially worth up to $1.
UCB to invest £1bn into UK under life sciences sector deal
UCB to invest £1bn into UK under life sciences sector deal
The government has published the second Life Sciences Sector Deal, detailing both public and private sector investments into the sector, including a £1 billion investment in UK research and developme...
Takeda shareholders agree to $60 bil Shire acquisition
Takeda shareholders agree to $60 bil Shire acquisition
Shareholders at Japanese drug giant Takeda on Wednesday approved a plan to buy Irish pharmaceuticals firm Shire in a deal worth around $60 billion, the biggest foreign takeover ever by a Japanese firm...
DEXTENZA® (dexamethasone ophthalmic insert) is the First Intracanalicular Insert for Drug Delivery
DEXTENZA® (dexamethasone ophthalmic insert) is the First Intracanalicular Insert for Drug Delivery
BEDFORD, Mass.
GBT Announces U.S. FDA Agrees with its Proposal Relating to Accelerated Approval Pathway for Voxelotor for the Treatment of Sickle Cell Disease and GBT Plans to Submit New Drug Application (NDA)
GBT Announces U.S. FDA Agrees with its Proposal Relating to Accelerated Approval Pathway for Voxelotor for the Treatment of Sickle Cell Disease and GBT Plans to Submit New Drug Application (NDA)
SOUTH SAN FRANCISCO, Calif.
New Parkinson's disease drug target revealed through study of fatty acids
New Parkinson's disease drug target revealed through study of fatty acids
The human brain is rich in lipids.
A cancer drug may help treat human papillomavirus infections
A cancer drug may help treat human papillomavirus infections
Preclinical experiments by University of Alabama at Birmingham researchers suggest the cancer drugs vorinostat, belinostat and panobinostat might be repurposed to treat infections caused by human papi...
FDA grants breakthrough device designation to artificial intelligence software for CTEPH pattern recognition from Bayer and MSD
FDA grants breakthrough device designation to artificial intelligence software for CTEPH pattern recognition from Bayer and MSD
Bayer announced today that the U.
FDA approves first treatment for Lambert-Eaton myasthenic syndrome, a rare autoimmune disorder
FDA approves first treatment for Lambert-Eaton myasthenic syndrome, a rare autoimmune disorder
The U.
Alkermes Announces Positive Topline Results From ENLIGHTEN-2 Phase 3 Study of ALKS 3831 in Patients With Schizophrenia
Alkermes Announces Positive Topline Results From ENLIGHTEN-2 Phase 3 Study of ALKS 3831 in Patients With Schizophrenia
DUBLIN, Nov.
FDA approves Meridian Bioscience's test for herpes in newborns
FDA approves Meridian Bioscience's test for herpes in newborns
(Reuters) - The U.
Catalog of Screening Compounds Screening Libraries Screening Compounds Building blocks
Drug Discovery Services News & Media Contact us
Payment systems
Policies & Terms     ©2023 ChemDiv     ChemistryOnDemand